Neola Medical AB (publ) (STO:NEOLA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.5600
+0.0450 (8.74%)
Aug 14, 2026, 4:56 PM CET

Neola Medical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.028.3210.129.839.7411.13
Revenue Growth
2.20%-17.75%2.97%0.84%-12.43%280.64%
Gross Profit
8.838.058.758.068.329.8
Operating Income
-11.99-11.1-10.8-9.63-10.12-6.65
Net Income
-11.95-11.02-10.06-9.01-10.35-6.65
Earnings Per Share
-0.15-0.14-0.14-0.16-0.40-0.47
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
9.9616.1219.5621.5840.0922.94
Net Cash Growth
-69.52%-17.56%-9.38%-46.17%74.76%37.80%
Net Cash Per Share
0.130.210.280.391.541.64
Cash & Investments
9.9616.1219.5621.5840.0922.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.07-11.01-10.77-6.54-8.5-6.93
Capital Expenditures
-0.06-0.06-0.15--0.1-0.17
Free Cash Flow
-12.14-11.07-10.92-6.54-8.6-7.1
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
97.83%96.71%86.47%82.04%85.41%88.05%
Operating Margin
-132.96%-133.40%-106.73%-97.97%-103.86%-59.80%
Pretax Margin
-132.49%-132.46%-99.48%-91.70%-106.26%-59.80%
Profit Margin
-132.49%-132.46%-99.48%-91.70%-106.26%-59.80%
FCF Margin
-134.53%-133.04%-107.90%-66.59%-88.27%-63.83%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.849.9314.0111.052.924.94